Filing Details

Accession Number:
0001144204-15-053636
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-03 16:06:06
Reporting Period:
2015-09-01
Filing Date:
2015-09-03
Accepted Time:
2015-09-03 16:06:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
352998 Igi Laboratories Inc IG Biological Products, (No Disgnostic Substances) (2836) 010355758
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555152 Jason Grenfell-Gardner C/O Igi Laboratories, Inc.
105 Lincoln Avenue
Buena NJ 08310
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-09-01 84,048 $7.94 187,624 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 28, 2015 and for the purpose of compliance by the Reporting Person with certain tax obligations.
  2. $7.9421 is the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.51 to $8.14. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.